Stay updated on Nab-sirolimus in Brain Cancer Clinical Trial

Sign up to get notified when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-sirolimus in Brain Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-08T13:54:53.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-01T06:23:22.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to include new drug combinations for treating high-grade glioma and glioblastoma, specifically mentioning nab-sirolimus in combination with lomustine, marizomib, and temozolomide. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    27%
    Check dated 2025-04-16T20:33:22.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T14:17:03.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:12:35.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-04T04:18:04.000Z thumbnail image

Stay in the know with updates to Nab-sirolimus in Brain Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.